Search results for: health insurance

UHC Announces New Copay Accumulator Policy Affecting In-Office Treatments

From the College | October 6, 2020

Editor’s note Nov. 23, 2020: As of Nov. 12, 2020, UHC has delayed implementation of the policy discussed below. See “UnitedHealthcare Delays Copay Accumulator Policy.” UnitedHealthcare (UHC) announced that, as of Jan. 1, 2021, providers will be required to report the amount their patients receive in copay assistance for office-administered treatments. UHC will then use…

Find Solutions to Navigate Telerheumatology in Your Practice

Carina Stanton | October 2, 2020

Experts weigh in on sustaining telerheumatology as a viable practice tool by sharing its history, potential and regulatory outlook post-pandemic at ACR Convergence 2020.

Guidance Coming for Anticipated COVID-19 Vaccine

Carina Stanton | September 4, 2020

What to vaccinate for and when to do so are challenges for rheumatologists and rheumatology professionals under normal circumstances. During the COVID-19 pandemic, even more questions are being raised, specifically regarding a possible vaccine for SARS-CoV-2. The ACR’s COVID-19 Practice and Advocacy Task Force is working on a guidance document to help ACR members address these pressing questions.

Advocacy 101 Teaches Legislative, Advocacy Basics

Vanessa Caceres | August 21, 2020

Bharat Kumar, MD, Advocacy 101 coordinator and Government Affairs Committee member, describes the virtual program designed to educate and empower rheumatology fellows in training, program directors and ARP members to advocate for issues that affect rheumatology practices and patients in advance of the Advocates for Arthritis that will take place virtually in September.

Talk It Up! 5th Annual Rheumatic Disease Awareness Month

Ruth Jessen Hickman, MD | August 17, 2020

This September marks the ACR’s fifth annual Rheumatic Disease Awareness Month (RDAM), which is designed to build support and advocate for patients with rheumatic diseases. This year’s theme, “My disease may be invisible, but I’m not,” emphasizes patients’ personal experiences…

ACR Leaders Discuss Hydroxychloroquine Issues with FDA Commissioner

From the College | August 10, 2020

The conversation with Stephen Hahn, MD, addressed challenges associated with hydroxychloroquine access during the COVID-19 public health emergency and handling patient concerns about potential cardiac side effects.

Denosumab Dosing Delays Tied to Increased Fracture Risk

Megan Brooks | July 27, 2020

NEW YORK (Reuters Health)—Denosumab injection delays of more than four months are associated with an increased risk of fracture compared with on-time injections, especially at the spine, new research indicates. “This study suggests the importance of timely denosumab administration when used for long-term osteoporosis management,” the researchers write in Annals of Internal Medicine.1 “When starting…

Financial Impacts of COVID-19 on Practices: Q&A with Norman Gaylis, MD

Kimberly Retzlaff | July 17, 2020

Community rheumatology practices are confronting a significant financial fallout from stay-at-home orders and fears that keep patients at home, as well as reimbursement challenges.

COVID-19: Practical Tips for Practices

Susan Bernstein | July 17, 2020

The ACR’s July 13 online town hall, “COVID-19 Guidance for Community Practices,” covered telehealth, safe clinic reopening and Department of Health & Human Services loans.

Incorporating Rheumatology Nurses into Training

Kurt Ullman | July 15, 2020

At the Johns Hopkins School of Medicine Division of Rheumatology, Baltimore, registered nurses (RNs) are an integral aspect of the rheumatology fellowship program. This gives the fellows information and insight into areas of practice they might not otherwise receive. “This [practice] is a result of our very strong belief that an integrated and interdisciplinary approach,…